XGN - Exagen Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
Total Revenue
39,814
32,440
26,807
Cost of Revenue
18,220
15,379
14,137
Gross Profit
21,594
17,061
12,670
Operating Expenses
Research Development
2,143
2,125
1,551
Selling General and Administrative
26,043
19,675
18,820
Total Operating Expenses
28,186
21,941
20,557
Operating Income or Loss
-6,592
-4,880
-7,887
Interest Expense
3,490
2,868
2,948
Total Other Income/Expenses Net
81
-318
-15,390
Income Before Tax
-9,889
-7,954
-26,180
Income Tax Expense
-
58
-549
Income from Continuing Operations
-9,947
-8,012
-25,631
Net Income
-9,947
-8,012
-25,631
Net Income available to common shareholders
-20,256
-7,694
-32,774
Reported EPS
Basic
-
-1.46
-6.21
Diluted
-
-1.46
-6.21
Weighted average shares outstanding
Basic
-
5,277
5,277
Diluted
-
5,277
5,277
EBITDA
-
-4,355
-22,562